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Abstract: 
Authors such as Francis Fukuyama, the President's Council on Bioethics, and George Annas 
have argued that biotechnological interventions that aim to promote genetic enhancement pose a 
threat to human nature. This paper clarifies what conclusions these critics seek to establish, and 
then shows that there is no plausible account of human nature that will meet the conditions 
necessary to support this position. Appeals to human nature cannot establish a prohibition against 
the pursuit of genetic enhancement. 
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I. INTRODUCTION 
 
There are a plethora of recent books and articles critical of actual and proposed biotechnological 
interventions. Both the targets and the criticisms are numerous. The targets include gene therapy, 
preimplantation genetic diagnosis, cloning, mood-altering drugs, and performance-enhancing 
drugs. Interventions that aim to enhance normal human traits especially draw the ire of critics. 
Among the many criticisms of such interventions, here I shall focus on those that appeal to 
human nature. In general, the charge is that some biotechnological interventions should be 
rejected because they pose a threat to human nature. My reasons for focusing on this particular 
line of argumentation are that it is common, it seems to have an audience that is wider than 
professional academics, and it has had political muscle. I shall argue that this entire approach to 
the issue is seriously misguided. One of my (modest) contentions is that if we ask the right 
questions, we can see why this approach is unhelpful. 
 
Chief among the proponents of this approach are Fukuyama (2002), the President's Council on 
Bioethics (2003) (under George Bush), and Annas (2005). The type of argument invoked urges 
us to defer to nature. Thus, the President's Council asserts that “not everything in the world is 
open to any use we may desire or devise” and that there are things “which should be left 
inviolate” (President's Council on Bioethics, 2003, 289). In the same vein, Fukuyama writes: 
“What is it that we want to protect from future advances in biotechnology? The answer is, we 
want to protect the full range of our complex, evolved natures against attempts at self-
modification” (Fukuyama, 2002, 172). Seeking to enhance normal human traits is said to be an 
unjustifiable attempt at self-modification. 
 
The first question that should be asked of these critics is this: What conclusion do they want to 
establish? This is important because as one reads their warnings, one might initially think that 
they have a point. But warnings can call attention to different moral conclusions. Here I shall 
distinguish two: 
 
Weaker conclusion: Go slowly. Be cautious when employing biotechnological interventions. 
 
I shall refer to this as “the precautionary stance” (not to be confused with the familiar 
precautionary principle1). 
 
Stronger conclusion: Do not go there at all. It is wrong to tamper with human nature. 
 
I shall refer to the stronger conclusion as “the prohibitionist stance.” All too frequently critics fail 
to specify which of these conclusions they seek to establish. But when we sort through the 
arguments, it is the stronger conclusion that they typically suppose they have supported. 
Certainly, that is what is communicated by the President's Council's use of the term “inviolate.”1 
 
II. PROHIBITIONS BASED ON HUMAN NATURE 
 
The most obvious instance of the type of argument that I want to assess is presented by 
Fukuyama in Our posthuman future. It unfolds over three chapters (Fukuyama, 2002, chs 7–9).2 
The argument has the following structure: 
 
(1) Humans have a higher moral status than other creatures. 
 
(2) Humans are morally equal to each other. 
 
(3) Moral values, including rights, are objective. 
 
(4) So there must be some feature of all humans that gives them moral significance (higher 
than other creatures but equal to each other). Call this feature “Factor X” (Fukuyama, 2002, 149–
53). 
 
Fukuyama takes premises (1), (2), and (3) as obvious. Granting these, it is the possession of 
Factor X that explains both the superior moral status of humans (to other living things) and that 
all humans are morally equal to each other. 
 
Given this argument and Fukuyama's goal of showing that certain biotechnological interventions 
should be banned absolutely, there are specific tasks that he needs to complete. Among other 
things, he needs to show the following: 
 
(1) That all humans have rights R1 … Rn (grounded in Factor X). 
 
(2) Rights R1 … Rn have correlated with them obligations O1 … On. 
 
(3) Identify the rights that are relevant to the biotechnological interventions being criticized. 
 
(4) Identify the content of the obligations correlative with the relevant rights. 
 
(5) Show that these obligations O1 … On prohibit the pursuit or use of the biotechnological 
interventions being criticized (e.g., anything that promotes genetic enhancement). 
 
In order to evaluate Fukuyama's position, we need to ask and answer several questions. What, 
according to Fukuyama, is Factor X? Is X unique to humans? If X is unique to humans, is X 
morally relevant? Put another way, does X support the rights and obligations that Fukuyama 
needs to make his case? I shall argue that not only is the answer to the last question negative but 
also that there is no (nontrivial) content for X that will support the sort of conclusions that 
Fukuyama, the President's Council, and others who pursue this type of argument seek to 
establish. 
 
In his search for Factor X, Fukuyama rejects a number of candidates. He posits and discusses 
consciousness, sociability, having language, having intelligence, making moral choices, and 
having emotions, and rejects each on grounds that it is not possessed only by humans 
(Fukuyama, 2002, 165–70). That brings him to the alternative that he introduces with the label 
“What to fight for.” What gives humans “dignity and a moral status higher than that of other 
living creatures” is described in the following passage: 
Factor X cannot be reduced to the possession of moral choice, or reason, or language, or 
sociability, or sentience, or emotions, or consciousness, or any other quality that has been put 
forth as a ground for human dignity. It is all of these qualities coming together in a human whole 
that make up Factor X. Every member of the human species possesses a genetic endowment that 
allows him or her to become a whole human being, an endowment that distinguishes a human in 
essence from other types of creatures (Fukuyama, 2002, 171). 
 
Whether what Fukuyama describes here as Factor X is unique to human beings, I do not know. 
But we can put that question aside and ask a more important one: What is the normative upshot 
of this? If this complex array of traits is morally relevant, what sort of rights and obligations does 
it generate? 
 
III. PROTECTING INDIVIDUAL HUMANS 
 
Recall that Fukuyama, the President's Council, and other advocates of this sort of argument hope 
to establish an absolute prohibition against the employment of biotechnological interventions 
that they dub “genetic engineering” and that seek the goal of “enhancement.” Fukuyama believes 
that these interventions tamper with Factor X and that it is wrong to do so. This suggests that the 
relevant right that Fukuyama believes that Factor X is the ground of is either the right not to be 
harmed or the right not to be put at risk. Factor X is valuable to its possessors, and so any 
diminution of it will be harmful. In particular, since Factor X gives its possessors a higher moral 
status than all other living creatures, a diminution of it will lower the moral standing of anyone to 
whom this happens. And even if per chance a given intervention did not destroy elements of 
Factor X, the mere fact that that is a possibility renders the employment of such an intervention 
as wrong. Either causing serious harm or putting individuals at risk of such harm is absolutely 
wrong. And in the cases envisioned, the losses will be a loss of rights and with that the 
disappearance of the obligations correlative with those rights. Emerging from all of this, then, is 
that possessors of Factor X have a right not to be changed and moral agents have an obligation 
not to attempt to do so. Some biotechnological interventions will produce such change. 
Therefore, employing them is wrong. 
 
The approach that grounds rights in the possession of valuable traits is neither unusual nor 
unreasonable. James Griffin, in his recent book On Human Rights, argues that what are properly 
called “human rights” can be seen as protections of our standing as normative agents. And, 
Griffin argues, agency requires autonomy, liberty, and a baseline level of resources. Thus, human 
rights generate obligations on agents to protect and promote the autonomy, liberty, and basic 
welfare of rights possessors (Griffin, 2008, 33 and chs 8, 9, and 10). 
 
Nevertheless, I contend that Fukuyama's specific argument fails and for multiple reasons. Even if 
a given intervention creates some risk of harm, it is implausible to hold that there is an absolute 
prohibition against pursuing a course of action that has risks associated with it. As we have 
learned from research ethics, many actions may be risky. The proper thing to do ethically is to 
determine the expected benefits, the risks, and the likelihood of each, and then decide 
accordingly. If the expected benefits outweigh the expected risks, and if the probability of the 
risks is small, it is not wrong to pursue such a course. Moreover, even if we could say with 
confidence that harm will come to some, there is not an absolute prohibition against harming 
others. Many medical interventions have associated with them a small probability of inflicting 
serious harm (e.g., death). If they are employed enough times, we can reasonably assume that 
there will be a small number of cases in which the harm is realized. But we do not conclude that 
using the intervention in question is prohibited. So neither risk nor actual harm is sufficient to 
establish an absolute prohibition. 
 
A defender of this argument might claim that my objections miss the point. In assessing risk, we 
should focus not only on the “probability” of harm but also on the “magnitude.” If something is 
correctly described as genetic engineering, one of the harms that is possible is a loss of one's 
humanity. Assuming that Factor X correctly delineates what is morally important about people 
and assuming that people have a higher moral status than other living creatures, then any 
intervention that threatens to erase Factor X imposes a risk of the highest magnitude. Or so a 
defender of the argument that appeals to human nature will claim. But this defense too is weak 
for several reasons. 
 
First, although describing an outcome as “losing one's humanity” sounds horrible, it is not 
obvious that it is the worst possible outcome. That same individual's death, for example, might 
be worse. Whether that is so presumably depends on how bad it is for one who has “lost his 
humanity.” Second, the probability of the occurrence is still relevant. Unless we hold that the 
mere “possibility” of a risk of “magnitude M” renders an intervention as absolutely wrong, we 
will have to factor in its probability and the probability and magnitude of the expected benefit in 
order to determine the permissibility of pursuing such an intervention. A third objection, 
however, is the most significant. What conditions must obtain before an individual has lost her 
humanity? Factor X designates a multiplicity of traits and, Fukuyama tells us, they are the 
essence of human nature and ground of rights possessed by humans. It is easy to see why a loss 
of all of those traits would be considered significant and harmful. But if only one of the traits is 
lost, we think that the being is still human. If some are no longer conscious or have an impaired 
capacity for reasoning, for example, we do not question their humanity. It is implausible to think 
that obligations are not owed to such beings. Yet if Fukuyama's argument is to support the 
stronger conclusion, it seems that he must say this. This third objection may arise because 
Fukuyama is making what I call “the all-or-nothing assumption.” This is the view that any given 
being has the full complement of moral rights or has none at all. In one striking passage, 
Fukuyama says: 
But in the political realm we are required to respect people equally on the basis of their 
possession of Factor X. You can cook, eat, torture, enslave, or render the carcass of any 
creature lacking Factor X, but if you do the same thing to a human being, you are guilty 
of a “crime against humanity” (Fukuyama, 2002, 150). 
Even if human beings have a higher moral status than all other creatures, it does not follow that 
all nonhumans have no moral standing at all. 
 
IV. PROTECTING THE HUMAN RACE 
 
All of my criticisms so far assume that Fukuyama believes that it is “individuals” who are 
threatened by any biotechnological intervention that seeks genetic enhancement. But much of 
what Fukuyama says suggests that it is not individuals, but humanity itself, that is threatened by 
these interventions. It is the human race that will be lost. Indeed, the title of Fukuyama's book is 
Our posthuman future. So the threat envisioned is much greater than what I have imagined. As 
with individuals, however, we need to unpack the nature of these alleged threats. It seems 
reasonable to think that the same three possibilities mentioned for individuals are candidates for 
understanding the threat to the species as a whole: genetic enhancement may impose serious 
“risks” on humanity, they may “harm” humanity by destroying it, or they may “change” 
humanity irrevocably and in such a way that humanity is harmed (by being made “less”). 
 
Before considering these possibilities, however, several questions must be contemplated. (a) 
What is it to harm “human” nature? (b) Is it possible to “change human” nature? and (c) If 
human nature can be changed, must it be wrong to do so?3 
 
Let us begin with question (b). There are more than 6 billion humans on the planet. Absent some 
kind of magic wand, it is initially difficult to see how any given genetic intervention could 
change human nature. Fukuyama is aware of this objection. As he notes, “Modifying, 
eliminating, or adding to those alleles on a small scale will change an individual's patrimony, but 
not the human race’s” (Fukuyama, 2002, 78–9). In spite of the obvious difficulty of altering the 
patrimony of the entire human race, Fukuyama nevertheless believes that we should worry. For 
one thing, he says, scientific and technological developments in the life sciences have proceeded 
much more rapidly than most anticipated. In addition, he says, we have already seen a 
population-level effect of some technologies (Fukuyama, 2002, 79–80). Here he has in mind the 
skewed sex ratios in certain Asian countries because of a number of people selecting against 
female fetuses. But this is a puzzling response to the objection. One can grant that there are 
distorted sex ratios in certain countries and one can agree that this is undesirable. It is hard to see, 
however, why this constitutes a change in human nature. If there is an essential human nature, 
that nature has not changed because of a skewed sex ratio in certain parts of the world. 
 
The more fundamental and troubling question is this: When is it accurate to say that human 
nature has been changed? Suppose that 1 billion people are subjected to some sort of germ-line 
gene therapy. One consideration that would have to be addressed is how much of a change must 
have been effected in those individuals in order for it to be true that they are no longer human. 
Fukuyama seems to think that any alteration whatsoever of the complex Factor X is sufficient to 
make the being less-than-human. This seems implausible, however. If these beings have an 
improved capacity for reasoning or a more potent immune system, but nothing else has changed, 
they would still be Homo sapiens. Some changes, no doubt, would lead us to say that those 
beings were no longer human—for example, if they could reproduce with each other but not with 
unaltered humans. But many changes fall well short of this. A second consideration that is 
relevant here is the status of the 5 billion (or more) people remaining whose genome has not 
been altered. They are still human. So the human race will have been neither eliminated nor 
harmed. Instead, a new species will have been created. And if anyone has been harmed by being 
made less-than-human, it will be specific individuals. 
 
This shows how difficult it is to get a handle on just what Fukuyama and others who advocate 
this view mean by changing human nature. But let's turn to question (c). Assuming that human 
nature can be changed, why should we think that it is always wrong to do so? And we should 
remind ourselves that Fukuyama, the President's Council, and others who endorse this argument 
that appeals to human nature are attempting to establish the prohibitionist stance. To see what is 
needed for this approach to succeed, imagine that we can change Y. It seems that if that is 
possible, then from an evaluative point of view we could change Y in any one of three ways: we 
could make Y worse, we could keep Y at the same level, or we could make Y better. So if it does 
make sense to say that through a series of genetic interventions agents can change human nature, 
in order to establish the “stronger” conclusion (the prohibitionist stance) proponents will have to 
show that any change in human nature is a change for the worse. If any change in human nature 
will be a change for the worse, then either (a) human nature is such that it cannot be improved 
upon or (b) human nature is such that it cannot be improved upon by the acts of human agents. 
 
To support line (a)—that human nature cannot be improved—it seems that proponents must hold 
one of two claims. They can say that human nature, as constituted, is that than which none 
greater can be conceived. This hardly seems plausible. As Fukuyama himself notes, there is a 
dark side to human nature. There is, for example, a human propensity for violence and 
aggression (Fukuyama, 2002, 44–5; Murray, 2007, 504). Focusing on nonmoral traits, it seems 
that if human memory were better or the immune system were more efficient, that would be an 
improvement. As for traits that are morally relevant, it seems that it would be an improvement if 
humans were less prone to jealousy and envy. If these possibilities are not improvements, the 
burden is on others to show that. Jonathan Glover states this point clearly in Choosing Children: 
If a good argument showed that some terrible characteristic—which by genetic means, 
we could change—was essential to being human, it might be better to transcend the limits 
of humanity rather than stay as we are. The idea of what is essential is a murky one, but, 
even if it were not, its importance is unclear. What is worth preserving is what is 
valuable, and the connection between the two is not obvious (Glover, 2006, 84). 
To deny this seems to commit one to what John Harris calls “the sanctity of the existing human 
genome” (Harris, 2007, 12). 
 
The other way to defend claim (a) is to say that human nature is a complex organic whole. Even 
if we can imagine a different being that is superior, there is no way to change humans as 
currently constituted to make them better. Tamper with any part of the organic unity, and the 
whole will be made worse. The President's Council suggests such a position when they write, 
“[T]he danger here is that we will become better in some area of life by diminishing ourselves in 
others, or that we will achieve superior results only by compromising our humanity …” 
(President's Council on Bioethics, 2003, 295; see also, Goering, 2000, 331–2). Fukuyama too 
seems to endorse this when he says that “we want to protect the full range of our complex, 
evolved natures against attempts at self-modification. We do not want to disrupt either the unity 
or the continuity of human nature …” (Fukuyama, 2002, 172; see also, 77, 98, 101, and 128). 
Such a claim is astonishing in its boldness. We can imagine producing beings with a capacity to 
reason better or with a more efficient immune system without having lost any other 
advantageous traits. This is logically possible, and it seems also to be physically possible. At the 
very least, those who deny its possibility must provide evidence. This will not be easy to do. 
Suppose that we have an intervention that makes humans less prone to jealousy. It seems that the 
only way we could know that beings created with this trait will also have had some vice 
exacerbated (or a new vice created) is through experience. Given that, the burden of proof is on 
those who endorse this version of organic unity.4 
 
Line (b) is a more interesting approach. It emphasizes human fallibility and the complexity of the 
world. As often as the term is used in this context, we might reasonably call this the “hubris 
objection.” The President's Council seems to have this criticism in mind when it says, “The 
human body and mind, highly complex and delicately balanced as a result of eons of gradual and 
exacting evolution, are almost certainly at risk from any ill-considered attempt at 
‘improvement’…” (President's Council on Bioethics, 2003, 287). Fukuyama makes a similar 
point when he writes, “There are good prudential reasons to defer to the natural order of things 
and not to think that human beings can easily improve on it through casual intervention” 
(Fukuyama, 2002, 97; see also 172). There is a certain ingenuity in this response. It says that 
human beings are so fallible that any attempt at self-improvement will backfire. There are 
several problems with this position, however. First, its implications are too broad. It is not only 
genetic enhancement that falls prey to this charge. Virtually, all new medical interventions would 
be similarly condemned. Second, this criticism is self-undermining. In the name of protecting 
that which is most valuable, human nature, from change, the critics tell us how limited and 
imperfect humans are. We must wonder how they, limited humans themselves, can know this. 
And we must also wonder why an imperfection can be accurately identified but not repaired. 
Unless these puzzles can be answered, this second line of argumentation is unconvincing. 
 
Is there any other way that those who appeal to human nature might argue for the prohibitionist 
stance? Sometimes their language suggests a different concern. Tampering with human nature 
may produce an altogether different being, a new species that will do harm to humans. At the 
conclusion of Beyond Therapy, the President's Council opines that “there is the risk of attacking 
human limitation altogether, seeking to produce a more-than-human being, one not only without 
illnesses, but also without foibles, failures, or foolishness” (President's Council on Bioethics, 
2003, 307). It certainly is odd to worry both that humans are so fallible that any intervention they 
devise is likely to backfire and also to think that humans can produce beings without illnesses or 
foibles. But that aside, this argument taps into a fear to which many science fiction writers often 
appeal. Frankenstein, Dr. Jekyll and Mr. Hyde, and The Time Machine come to mind. Such a 
fear seems to motivate George Annas. He worries that the employment of genetic enhancement 
will create a new species of “posthumans,” a species that will regard humans as inferior and will 
subject them to exploitation, enslavement, and perhaps genetic genocide (Annas, 2005, 51). 
Some of the most enthusiastic supporters of biotechnology have themselves posited the 
possibility of creating a being superior to humans (Silver, 1997, 246). Human nature must be 
protected from such change, Annas says. He goes so far as to suggest that those who attempt to 
enhance human nature through genetic interventions are guilty of crimes against humanity 
(Annas, 2005, 40). To take these concerns seriously, we have to believe that attempts at human 
enhancement will create a new species, that it will be superior to humans, and that it will use its 
powers to dominate humans. These worries are understandable if one adopts what I earlier called 
the all-or-nothing assumption and if one holds that the more-than-humans that are created will 
not be bound by morality. But each of these assumptions requires an affirmative defense that has 
not yet been provided. Moreover, the feared scenario cannot obtain unless the newly created 
species thrives and reproduces prolifically, and unless humans will be defenseless against it. 
These assumptions too are in need of justification. 
 
One other way that critics of biotechnology appeal to human nature does not go so far as to posit 
the creation of a new species. Instead, they worry what will soon become of our species. This is a 
particular instance of the charge that biotechnology will make humans worse. But with this 
criticism, the charge is that it will make them worse not by causing suffering, but rather by being 
too successful at alleviating it. The President's Council puts it this way: 
[T]here appears to be a connection between the possibility of feeling deep unhappiness 
and the prospects for achieving genuine happiness. If one cannot grieve, one has not truly 
loved. To be capable of aspiration, one must know and feel lack … [I]f human fulfillment 
depends on our being creatures of need and finitude and therewith of longings and 
attachment, there may be a double-barreled error in the pursuit of ageless bodies and 
factitiously happy souls … (President's Council on Bioethics, 2003, 299). 
Fukuyama makes a similar point. He complains that biotechnology seeks to make us less 
complex. He continues: 
The answer lies in the constant pressure that exists to reduce the ends of biomedicine to 
utilitarian ones – that is, the attempt to reduce a complex diversity of natural ends and 
purposes to just a few simple categories like pain and pleasure, or autonomy. There is in 
particular a constant predisposition to allow the relief of pain and suffering to 
automatically trump all other human purposes and objectives. For this will be the 
constant trade-off that biotechnology will pose: we can cure this disease, or prolong this 
person's life, or make this child more tractable, at the expense of some ineffable human 
quality like genius, or ambition, or sheer diversity (Fukuyama, 2002, 172). 
Readers of Huxley's Brave New World can understand why Fukuyama is fond of comparing the 
posthuman world that he believes will be created by biotechnology with the world described in 
that novel. One way to understand this criticism is in terms of organic unity (mentioned earlier). 
Tamper with one part of human nature in order to achieve an improvement, and we are apt to 
effect a greater setback in another part. This sounds like an odd tribute to suffering. Fukuyama 
realizes this. He says: 
No one can make a brief in favor of pain and suffering, but the fact of the matter is that 
what we consider to be the highest and most admirable human qualities, both in ourselves 
and in others, are often related to the way we react to, confront, overcome, and frequently 
succumb to pain, suffering, and death. In the absence of these human evils there would be 
no sympathy, compassion, courage, heroism, solidarity, or strength of character. A person 
who has not confronted suffering or death has no depth” (Fukuyama, 2002, 173). 
It is rather extraordinary that anyone is concerned that humans (or posthumans) will get to the 
point that they will not grieve, that they will not feel lacking, and that they will suffer too little. 
But let us grant that this is a possibility. The issue then is whether mere possibilities are 
sufficient to prohibit absolutely the pursuit of certain interventions. Is this a case of unjustifiably 
subjecting others to risk? If we adopt such a position, the freedom to pursue any new research 
will be in jeopardy; progress will be imperiled. These costs are too stiff of a price to pay for mere 
possibilities. Finite living beings have always faced obstacles, have adapted to them, and have 
encountered new problems. There is no intervention on the horizon that is likely to stop such a 
cycle. 
 
V. WHERE DOES THIS LEAVE US? 
 
The argument that appeals to human nature to support the prohibitionist stance fails. Asserting 
that various actual or proposed biotechnological interventions pose a threat to human nature is 
rhetorically powerful. But analysis suggests that the argument cannot succeed. We must first ask 
who the potential victim of these interventions is. If it is “individuals” who may suffer a loss of 
their humanity, then proponents of the argument must complete several daunting tasks. They 
must explain what human nature is, why losing it is always harmful, and why the mere 
possibility that an intervention might deprive an individual of her humanity thereby renders it 
wrong to pursue. I am skeptical that the first two tasks can be completed. But even if they can, 
how can they show that the mere possibility of certain outcome, regardless of its probability and 
regardless of any other expected benefits or risks, can make wrong the pursuit of an intervention 
that might produce such an outcome? If, on the other hand, it is the “human race” that is the 
potential victim, then defenders of this argument must show that human nature can be changed 
and that any implemented will be a change for the worse. I remain puzzled about how we can 
know that human nature has been changed. But even if we can know this, the assumption that 
any change will be a change for the worse lacks credibility. That can be true only if human 
nature as currently constituted is that which none greater than can be conceived, or is a 
combination of factors which is such that if any is disrupted the whole will be worse, or cannot 
be made better by human agency because of fallibility. None of these possibilities is plausible. 
Moreover, it is hard to imagine what content for human nature will enable this argument to 
succeed. 
 
Let's step back and see how we arrived at this point. Fukuyama, the President's Council, and 
other defenders of the argument take as their starting points that humans have the highest moral 
status, that all humans are equal, and that they possess the same rights. This requires them to 
hold that all humans share a set of morally relevant traits that serve as the basis of their rights. 
They then must articulate what these traits are and why they generate the obligations that these 
proponents believe that all agents have. In particular, they must show that there is an obligation 
not to attempt to alter human nature because to do so is to impose a risk of harm. For that to 
succeed, however, it is not enough that the traits in question give human beings a higher moral 
status than any other creature. It must also be the case that it can be changed and that no change 
can be an improvement. If this is implausible, maybe the starting point is wrong. Maybe moral 
status in general and rights in particular are not possessed in virtue of species membership. 
Instead, perhaps we should focus on morally relevant traits, such as the capacity to suffer and the 
capacity to make choices. Normal adult human beings have these capacities, and as a result they 
possess rights that generate obligations. Clearly other creatures have some of these traits, and so 
other creatures may possess rights too. Do humans have the highest moral status? They might; 
for it is possible that whereas many creatures possess these traits, on a continuum humans 
possess them to a greater degree. But is it even important to say that humans have the highest 
moral status? It is not clear that there is a moral competition going on; what is important is who 
has obligations and to whom are the obligations owed. We can answer those questions without 
drawing global conclusions about the status of various species. 
 
Fukuyama may object, however, that this approach threatens the view that all humans are 
morally equal. Fukuyama properly laments social practices like slavery and female circumcision 
(Fukuyama, 2002, 113), and he seems to believe that they can be shown to be wrong only if they 
violate rights that are possessed by all humans. If rights are possessed in virtue of traits like the 
capacity to make choices and the capacity to suffer, then some might argue that women or 
African-Americans do not have these traits to the same degree as males or Caucasians, and 
therefore they lack some rights. But there are two obvious responses to this concern. First, such 
an argument is sophistical. People can claim anything, but that does not make it true. And 
second, sophistical argumentation can be made about one's standing as a full human being too. 
Anyone who is willing to say that women or African-Americans are not as capable of making 
choices as Caucasian males are also apt to be willing to say that they are not as fully human as 
males. Either way, it is a bad argument; either way, equality can be defended. 
 
Nevertheless, Fukuyama may seem to be in a better position to defend equality; after all, genetic 
tests can determine whether individuals are human. But this highlights an additional issue. 
Fukuyama himself struggles with what to say about members of Homo sapiens who lack some of 
the traits that constitute Factor X (Fukuyama, 2002, 174–7). He acknowledges that embryos, 
infants, and individuals with advanced dementia lack some of the relevant traits. He concedes 
that “individuals possess those traits in greater or lesser amounts” (Fukuyama, 2002, 175), and 
he worries that this might lead to “a gradation of rights” (Fukuyama, 2002, 174). On either 
approach, then, there are apparently problematic cases.5 
 
If biotechnological interventions that aim for genetic enhancement are not to be rejected because 
they pose a threat to human nature, where does that leave us? There might, of course, be other 
arguments in support of the prohibitionist stance. Critics have charged that enhancement 
technologies may exacerbate the gap between the “haves” and the “have nots,” that the 
availability of such techniques will have an adverse effect on the parent–child relationship, and 
that this is a foolish use of resources. Each of these criticisms will have to be considered on its 
own merits. In the meantime, I suggest dropping the apocalyptic language about human nature 
being endangered and crimes against humanity being perpetrated. Instead, the focus should be on 
what degree of risk is permissible and for what ends. Any untested intervention is experimental 
and should be judged accordingly. Our society tries to estimate the expected benefits and the 
likely risks of any new procedures, and it should do so for interventions that aim for 
enhancement (for a thorough discussion of this, see Mehlman and Berg, 2008). Both the 
probability and magnitude of those benefits and risks are relevant. And maybe some benefits are 
not suitable to pursue. But after all of this is taken into account, if the balance of benefits to risks 
looks prima facie promising, research should be allowed to proceed, but starting with small 
numbers. This, in effect, is the precautionary stance. It is rather mundane and unexciting. But it 
is defensible. It does not allow mere possibilities to generate prohibitions. Instead, it starts with 
available evidence, is cognizant of the fact that untoward outcomes can occur, and so proceeds 
incrementally. It is not rhetorically powerful to say, “Be cautious,” but such a policy allows for 
progress while still protecting moral rights. 
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Footnotes 
 
1 Even the familiar “precautionary principle” is sometimes interpreted in these two ways. The 
stronger interpretation urges that if there is doubt, do not go there. See Steve Rayner's 
“Foreword” to Harris J. 2007. Enhancing Evolution: The Ethical Case for Making Better People. 
Princeton, NJ: Princeton University Press. xii. 
 
2 A similar argument is advanced by Annas, G. 2005. American Bioethics: Crossing Human 
Rights and Health Law Boundaries. New York: Oxford University Press, 37–40. For a critical 
discussion of Annas's argument, see Fenton, E. 2008. Genetic enhancement—A threat to human 
rights? Bioethics 22:1–7. 
 
3 As Sandra Shapshay has reminded me, another important question to ask here is whether the 
essentialist account of human nature presupposed here is compatible with evolutionary theory. 
 
4 As Norman Dahl has pointed out to me in correspondence, the account of human nature in 
Fukuyama and the President's Council is Aristotelian. And Fukuyama frequently acknowledges 
his debt to Aristotle (e.g., 157–8 and 164–5). Still, such a substantive account needs an 
independent defense. Moreover, as Dahl has suggested, it is not obvious that the Aristotelian 
account would condemn using enhancement technology to treat disease, nor is it clear that it 
would prohibit humans from producing offspring that are “more than human.” 
 
5 Griffin (2008), 34–5, acknowledges that not all Homo sapiens are normative agents, and so 
some may lack human rights (though they may still have some moral standing). Griffin also 
concedes that there might be normative agents that are not human, but he focuses on the cases 
with which we are familiar. Readers may wonder why Griffin continues to use the expression 
“human rights.” He attempts to explain this in chapter 1. 
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